Pharmaceutical News and Articles

Too Much Fasting in Hospital Could Have Downside for Orthopedic Surgery Patients

and longer hospital stays, an average nine days versus four days.The findings were presented Saturday at the American Society of Anesthesiologists annual meetin

Blood Test Might Spot Women in Labor at Risk for Preeclampsia

checking blood pressure more frequently, keeping fluid levels stable and placing an early epidural for pain management.Shang said this ratio should be assessed

Flesh-Eating Bacteria Cases Rise in Florida in Wake of Storms

reported the largest increases of the bacteria, which is commonly found in warm coastal waters, CNN reported. Before Hurricane Helene made landfall on Sept. 26,

Walking Pneumonia Cases Spike Among Young Kids

Walking pneumonia cases are surging among young children in the United States, federal health officials warn. Bacterial infections caused by Mycoplasma pneumoni

Biden Proposes That Insurers Cover Over-the-Counter Birth Control

Health insurers would be required to cover the cost of over-the-counter birth control and emergency contraception under new rules proposed by the White House on

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Glaukos Corporation (NYSE GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal d

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants

RAHWAY, N.J., Oct. 17, 2024 Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the presentation of positive results from th

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

Gilead Sciences, Inc. (Nasdaq GILD) and Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2 clini

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease